Tower Bridge Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.92M Sell
22,487
-335
-1% -$29.9K 0.19% 92
2025
Q4
$1.8M Sell
22,822
-165
-0.7% -$12.9K 0.18% 87
2025
Q3
$1.84M Sell
22,987
-400
-2% -$34.1K 0.18% 89
2025
Q2
$2.13M Sell
23,387
-2,000
-8% -$183K 0.23% 86
2025
Q1
$2.38M Sell
25,387
-650
-2% -$58.2K 0.27% 86
2024
Q4
$2.37M Sell
26,037
-100
-0.4% -$9.54K 0.25% 87
2024
Q3
$2.71M Buy
26,137
+314
+1% +$32K 0.28% 85
2024
Q2
$2.51M Sell
25,823
-2,500
-9% -$231K 0.28% 82
2024
Q1
$2.55M Sell
28,323
-14,775
-34% -$1.25M 0.26% 94
2023
Q4
$3.44M Sell
43,098
-4,800
-10% -$361K 0.3% 78
2023
Q3
$3.41M Sell
47,898
-3,900
-8% -$292K 0.32% 81
2023
Q2
$3.99M Sell
51,798
-4,375
-8% -$339K 0.37% 73
2023
Q1
$4.22M Sell
56,173
-1,785
-3% -$133K 0.35% 80
2022
Q4
$4.57M Sell
57,958
-500
-0.9% -$37.5K 0.38% 76
2022
Q3
$4.11M Sell
58,458
-528
-0.9% -$41.4K 0.36% 80
2022
Q2
$4.73M Buy
58,986
+1,300
+2% +$102K 0.39% 78
2022
Q1
$4.37M Sell
57,686
-6,302
-10% -$499K 0.29% 86
2021
Q4
$5.46M Sell
63,988
-3,200
-5% -$250K 0.34% 80
2021
Q3
$5.08M Sell
67,188
-2,200
-3% -$175K 0.34% 77
2021
Q2
$5.64M Sell
69,388
-4,803
-6% -$393K 0.38% 74
2021
Q1
$5.85M Sell
74,191
-3,551
-5% -$278K 0.44% 71
2020
Q4
$6.65M Buy
77,742
+6,620
+9% +$547K 0.54% 58
2020
Q3
$5.49M Buy
71,122
+350
+0.5% +$26.7K 0.56% 60
2020
Q2
$5.18M Sell
70,772
-325
-0.5% -$23.1K 0.58% 55
2020
Q1
$4.72M Buy
71,097
+8,715
+14% +$615K 0.62% 53
2019
Q4
$4.29M Sell
62,382
-4,485
-7% -$306K 0.45% 71
2019
Q3
$4.46M Sell
66,867
-325
-0.5% -$23.6K 0.49% 61
2019
Q2
$4.82M Hold
67,192
0.54% 62
2019
Q1
$4.61M Buy
67,192
+1,425
+2% +$92K 0.53% 62
2018
Q4
$3.91M Buy
65,767
+1,368
+2% +$85.6K 0.5% 63
2018
Q3
$4.31M Sell
64,399
-7,430
-10% -$495K 0.45% 65
2018
Q2
$4.66M Sell
71,829
-9,623
-12% -$629K 0.52% 64
2018
Q1
$5.84M Sell
81,452
-7,845
-9% -$565K 0.65% 58
2017
Q4
$6.74M Sell
89,297
-6,463
-7% -$472K 0.72% 53
2017
Q3
$6.98M Sell
95,760
-9,035
-9% -$651K 0.79% 51
2017
Q2
$7.77M Sell
104,795
-5,075
-5% -$377K 0.89% 45
2017
Q1
$8.04M Sell
109,870
-36,426
-25% -$2.55M 0.94% 40
2016
Q4
$9.57M Sell
146,296
-25,873
-15% -$1.77M 1.16% 32
2016
Q3
$12.8M Sell
172,169
-5,495
-3% -$406K 1.55% 20
2016
Q2
$13M Sell
177,664
-2,698
-1% -$192K 1.62% 17
2016
Q1
$12.7M Buy
180,362
+1,758
+1% +$117K 1.59% 18
2015
Q4
$11.9M Buy
178,604
+6,539
+4% +$435K 1.55% 22
2015
Q3
$10.9M Buy
172,065
+5,170
+3% +$338K 1.5% 23
2015
Q2
$10.9M Buy
166,895
+3,796
+2% +$258K 1.38% 25
2015
Q1
$11.3M Buy
163,099
+1,689
+1% +$117K 1.43% 21
2014
Q4
$11.2M Buy
161,410
+622
+0.4% +$42K 1.37% 24
2014
Q3
$10.5M Buy
160,788
+59,191
+58% +$3.9M 1.32% 27
2014
Q2
$6.93M Buy
101,597
+1,950
+2% +$131K 0.85% 50
2014
Q1
$6.46M Buy
99,647
+8,030
+9% +$506K 0.83% 52
2013
Q4
$5.97M Sell
91,617
-1,220
-1% -$78.1K 0.78% 54
2013
Q3
$5.51M Buy
92,837
+1,639
+2% +$97.1K 0.79% 53
2013
Q2
$5.22M Buy
+91,198
New +$5.41M 0.77% 54

Other funds holding CL

Tower Bridge Advisors's CL Position: Q1 2026 in Review

Tower Bridge Advisors reduced its Colgate-Palmolive (CL) stake by 1.5% in Q1 2026, selling an estimated $29.9K and leaving 22,487 shares worth $1.92M. The position accounts for 0.19% of the portfolio, ranked #92.

Tower Bridge Advisors first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $13M in Q2 2016. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Tower Bridge Advisors held 22,487 shares of Colgate-Palmolive worth $1.92M as of Q1 2026.
  • Tower Bridge Advisors sold 335 Colgate-Palmolive shares in Q1 2026, an estimated $29.9K.
  • Colgate-Palmolive made up 0.19% of Tower Bridge Advisors's portfolio in Q1 2026, its #92 holding.
  • Tower Bridge Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Tower Bridge Advisors's Colgate-Palmolive position peaked at $13M in Q2 2016.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Tower Bridge Advisors's 13F filing for Q1 2026, filed 12 May 2026.